The Scientist - Home

Editor's Note: The news items on this page all originated from the American Association for the Advancement of Science annual meeting in Anaheim, Calif., Jan. 21-26. PLAQUE ATTACK A host of studies have bitten off the task of linking periodontitis with coronary heart disease. But without more evidence, scientists may find any cause-and-effect relationship between tooth disease and heart attacks hard to swallow, admitted James D. Beck, professor of dental ecology, at the University of North Caro

Kits and chips will routinely screen for the genetic implications of new drugs within the next 10 years, and therapeutics is becoming a science as opposed to an art. The Food and Drug Administration (FDA) will expect pharmaceutical companies to have molecular insights into how drugs work and how they are metabolized. Such data will reduce idiosyncratic reactions to drugs. These were the opinions of panelists at a presentation called "Developing Prescriptions with a Personal Touch: The Human G

Discoveries in genomics will bring about enormous changes in the scientific community, but these changes have "caught many sectors of the biomedical academic community off guard," cautions Allen W. Cowley Jr., professor of medicine at the Medical College of Wisconsin. Cowley calls "scientific manpower preparedness" a hurdle science must overcome to fully benefit from the Human Genome Project. A shortage of scientists appropriately trained to define the physiological function of genes and expre

The problem and the solution seem obvious: Scientists are training many more graduate students than are needed for available academic positions, and science illiteracy in the United States is rampant. Newly trained scientists working outside academia might ease the glut, plus perhaps pass their enthusiasm and knowledge to the public. Statistics tell the story. According to the National Research Council (NRC), in 1985, 3,791 Ph.D.s were granted in life sciences, and the job market held 20,377 t

Courtesy of ARIAD Pharmaceuticals In the gene therapy system devised by Penn and ARIAD researchers, the adeno-associated virus is injected into the body to deliver the desired gene (top left), and a drug in pill form is given orally to activate gene expression (top right). Researchers demonstrated a strong correlation between the amount of drug administered and the resulting increase in the amount of protein produced (center). Scientists attempting to devise successful, efficient gene therapy

On Jan. 14, the day before Science published an article on a formalin-fixed fused immunogen that induced neutralizing antibodies to HIV-1 envelope glycoproteins,1 Jack Nunberg's telephone rang endlessly. Nunberg, head of the Montana Biotechnology Center at University of Montana, Missoula, is senior author of the paper, coauthored by his former graduate student Rachel LaCasse (now at University of Alabama, Birmingham), colleagues at University of Montana, and two scientists at New York Universit

After years of clinical studies in Germany, St. John's wort (Hypericum perforatum) is poised to undergo scientific scrutiny in the United States as a treatment for depression. Never clinically tested in this country, the yellow-blossomed, roadside weed, native to much of America's Northwest and to many other parts of the world, is now the focus of four such trials. Perhaps foremost among them is a $4.3 million study funded by the Office of Alternative Medicine (OAM) in the National Institutes

Editor's Note: In this essay, the authors--both scientists and writers--discuss recent news stories on evolution and express their opinions on how the stories were handled by the mainstream press. Evolution took center stage at the National Association of Biology Teachers (NABT) annual meeting in Reno, Nev., Nov. 3-8, 1998. If the teachers needed a theme, evolution was a logical choice--after all, it underlies and unifies contemporary biology. But NABT had other fish to fry. Despite a spate of c

BARKING UP THE SAME TREE Ralston Purina announced Jan. 12 an initiative to unite efforts to map the dog genome, consolidating data and planning for more. Most markers accumulated so far hail from the Baker Institute at Cornell University. The linkage map, currently consisting of about 400 markers, provides signposts along the 78 chromosomes to direct sequencing efforts. At the heart of the project are blood samples from 16 multigenerational canine families. The dog genome hardly reflects natu

Postdocs supported by National Institutes of Health training grants will soon see their funding increase by about 25 percent, but even NIH officials agree that the boost alone won't fix a program that has set stagnant stipends for years. In 1996, new postdocs received $20,292 under NIH's National Research Service Awards (NRSA), an amount that increased $708 for the 1998 fiscal year. The new entry-level salary of $26,256 for the 1999 fiscal year--and the new senior level of $41,268, up from $33

Phrases such as "bidding war," "invest now," and "panic over short supply" evoke images of brave new drugs. An apologetic "It's on back order" is a common refrain from L.L. Bean or Land's End. But these phrases are being applied to the fetal pig, a staple of the biology teaching laboratory as a model of vertebrate anatomy. The foot-long beasts, once considered mere slaughterhouse waste, now bring in more bacon than a nice pair of pork chops. Spiraling fetal pig prices have biology instructors s

When Katherine Osteryoung started her postdoctoral fellowship in Elizabeth Vierling's laboratory at the University of Arizona, Tucson, she wanted to work on heat shock proteins, which cells make in response to stress. Chloroplast division was the farthest thing from her mind. But science, which is no stranger to serendipity, had other plans. Plastids, including chloroplasts, are descendants of cyanobacterial endosymbionts. Like their ancestors, they divide by fission, ensuring continuity throu